{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:39:02Z","timestamp":1788284342883,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T00:00:00Z","timestamp":1394496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chemistry Central Journal"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1752-153x-8-17","type":"journal-article","created":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T12:05:43Z","timestamp":1394539543000},"source":"Crossref","is-referenced-by-count":23,"title":["Development and validation of LC\/MS\/MS method for the simultaneous determination of montelukast, gliclazide, and nifedipine and its application to a pharmacokinetic study"],"prefix":"10.1186","volume":"8","author":[{"given":"Essam","family":"Ezzeldin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisreen F","family":"Abo-Talib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa H","family":"Tammam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelaaty A","family":"Shahat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,11]]},"reference":[{"key":"771_CR1","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2165\/00002018-200326070-00004","volume":"26","author":"L Garc\u00eda-Marcos","year":"2003","unstructured":"Garc\u00eda-Marcos L, Schuster A, P\u00e9rez-Yarza EG: Benefit-risk assessment of antileukotrienes in the management of asthma. Drug Saf. 2003, 26: 483-518. 10.2165\/00002018-200326070-00004.","journal-title":"Drug Saf"},{"key":"771_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2165\/00003495-199346010-00007","volume":"46","author":"KJ Palmer","year":"1993","unstructured":"Palmer KJ, Brogden N: Gliclazide an update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus. Drugs. 1993, 46: 92-125. 10.2165\/00003495-199346010-00007.","journal-title":"Drugs"},{"key":"771_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1126\/science.2432656","volume":"235","author":"RJ Miller","year":"1987","unstructured":"Miller RJ: Multiple calcium channels and neuronal function. Science. 1987, 235: 46-52. 10.1126\/science.2432656.","journal-title":"Science"},{"key":"771_CR4","doi-asserted-by":"publisher","first-page":"737","DOI":"10.2165\/00003495-199141050-00006","volume":"41","author":"D Murdoch","year":"1993","unstructured":"Murdoch D, Brogden RN: Sustained release nifedipine formulations: an appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders. Drugs. 1993, 41: 737-779.","journal-title":"Drugs"},{"key":"771_CR5","first-page":"940","volume-title":"Martindale The Extra Pharmacopoeia","author":"SC Weetman","year":"2002","unstructured":"Weetman SC: Martindale The Extra Pharmacopoeia. 2002, London: Royal Pharmaceutical Society, 940-946. 33","edition":"33"},{"key":"771_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.farmac.2005.04.004","volume":"60","author":"I Alsarra","year":"2005","unstructured":"Alsarra I, Al-Omar M, Gadkariem EA, Belal F: Voltammetric determination of montelukast sodium in dosage forms and human plasma. Farmaco. 2005, 60: 563-567. 10.1016\/j.farmac.2005.04.004.","journal-title":"Farmaco"},{"key":"771_CR7","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jssc.200700591","volume":"31","author":"Y Shakalisava","year":"2008","unstructured":"Shakalisava Y, Regan F: Determination of montelukast sodium by capillary electrophoresis. J Sep Sci. 2008, 31: 1137-1143. 10.1002\/jssc.200700591.","journal-title":"J Sep Sci"},{"key":"771_CR8","first-page":"823","volume":"60","author":"I Alsarra","year":"2005","unstructured":"Alsarra I, Khalil NY, Sultan M, Al-Ashban R, Belal F: Spectrofluorometric determination of montelukast in dosage forms and spiked human plasma. Pharmazie. 2005, 60: 823-826.","journal-title":"Pharmazie"},{"key":"771_CR9","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1134\/S1061934809070065","volume":"64","author":"M Saeed Arayne","year":"2009","unstructured":"Saeed Arayne M, Sultana N, Hussain F: Spectrophotometric method for quantitative determination of montelukast in bulk, pharmaceutical formulations and human serum. J Anal Chem. 2009, 64: 690-695. 10.1134\/S1061934809070065.","journal-title":"J Anal Chem"},{"key":"771_CR10","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/bmc.1189","volume":"23","author":"DV Bharathi","year":"2009","unstructured":"Bharathi DV, Hotha KK, Jagadeesh B, Mullangi R, Naidu A: Quantification of montelukast, selective cysteinyl leukotriene receptor (CysLT1) antagonist In human plasma by liquid chromatography- mass spectrometry- validation and its application to a human pharmacokinetic study. Biomed Chromatogr. 2009, 23: 804-810. 10.1002\/bmc.1189.","journal-title":"Biomed Chromatogr"},{"key":"771_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jchromb.2008.05.017","volume":"869","author":"P Sripalakit","year":"2008","unstructured":"Sripalakit P, Kongthong B, Saraphanchotiwitthaya A: A simple bioanalytical assay for determination of montelukast in human plasma- application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2008, 869: 38-44. 10.1016\/j.jchromb.2008.05.017.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"771_CR12","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1023\/B:PHAM.0000041445.76931.27","volume":"21","author":"GA Smith","year":"2004","unstructured":"Smith GA, Rawls CM, Kunka RL: An automated method for the determination of montelukast in human plasma using dual-column HPLC analysis and peak height summation of the parent compound and its photo degradation product. Pharm Res. 2004, 21: 1539-1544.","journal-title":"Pharm Res"},{"key":"771_CR13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jchromb.2007.08.003","volume":"858","author":"R Papp","year":"2007","unstructured":"Papp R, Luk P, Mullett WM, Kwong E: A rapid and sensitive method for the quantitation of montelukast in sheep plasma using liquid chromatography\/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2007, 858: 282-286. 10.1016\/j.jchromb.2007.08.003.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"771_CR14","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.jpba.2008.07.007","volume":"48","author":"M Saravanan","year":"2008","unstructured":"Saravanan M, Siva Kumari K, Pratap Reddy P, Naidu MN, Moses Babu J, Srivastava AK, Lakshmi Kumar T, Chandra Sekhar BV, Satyanarayana B: Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodium. J Pharm Biomed Anal. 2008, 48: 708-715. 10.1016\/j.jpba.2008.07.007.","journal-title":"J Pharm Biomed Anal"},{"key":"771_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jpba.2007.07.014","volume":"45","author":"MM Al Omari","year":"2007","unstructured":"Al Omari MM, Zoubi RM, Hasan EI, Khader TZ, Badwan AA: Effect of light and heat on the stability of montelukast in solution and in its solid state. J Pharm Biomed Anal. 2007, 45: 465-471. 10.1016\/j.jpba.2007.07.014.","journal-title":"J Pharm Biomed Anal"},{"key":"771_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.chroma.2007.02.060","volume":"1156","author":"TH Hoang","year":"2007","unstructured":"Hoang TH, Sharma R, Susanto D, Di Maso M, Kwong E: Microwave-assisted extraction of active pharmaceutical ingredient from solid dosage forms. J Chromatogr A. 2007, 1156: 149-153. 10.1016\/j.chroma.2007.02.060.","journal-title":"J Chromatogr A"},{"issue":"2","key":"771_CR17","first-page":"42","volume":"7","author":"K Prashanth Kumar","year":"2012","unstructured":"Prashanth Kumar K, Akiful Haque M, Pradeep Kumar T, Nivedita G, Hasan Amrohi S, Prasad VV, Prakash VD: Simultaneous determination of Montelukast sodium and fexofenadine hydrochloride in combined dosage form by using RP-HPLC method. World J Chem. 2012, 7 (2): 42-46.","journal-title":"World J Chem"},{"key":"771_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3797\/scipharm.1002-07","volume":"78","author":"RC Balasekhara","year":"2010","unstructured":"Balasekhara RC, Bahlul ZA, Babu RC, Mukkanti K, Chandrasekhar BK: Method development and validation of Montelukast in human plasma by HPLC coupled with ESI-MS\/MS: application to a bioequivalence study. Sci Pharm. 2010, 78: 411-422. 10.3797\/scipharm.1002-07.","journal-title":"Sci Pharm"},{"key":"771_CR19","first-page":"135","volume":"2","author":"S Alireza","year":"2010","unstructured":"Alireza S, Afshin Z, Seyed MF, Arash K, Babak M: Rapid and sensitive determination of Montelukast in human plasma by high performance liquid chromatographic method using monolithic column: application to pharmacokinetic studies. J Bioequiv Availab. 2010, 2: 135-138.","journal-title":"J Bioequiv Availab"},{"key":"771_CR20","first-page":"277","volume":"1","author":"R Revathi","year":"2010","unstructured":"Revathi R, Saravanan VS, Mohan Raj P, Ethiraj T, Ganesan V: Spectrophotometric Estimination of Gliclazide in Bulk and Pharmaceutical Dosage Forms. Int Res J Pharm. 2010, 1: 277-281.","journal-title":"Int Res J Pharm"},{"key":"771_CR21","first-page":"338","volume":"3","author":"AJ Samina","year":"2011","unstructured":"Samina AJ, Snehal PM, Poonam SK, Yogesh VP, Kishor BB: Development and validation of UV spectrophotometric method for the determination of Gliclazide in tablet dosage form. Der Pharma Chemica. 2011, 3: 338-343.","journal-title":"Der Pharma Chemica"},{"key":"771_CR22","first-page":"259","volume":"3","author":"S Pinderjit","year":"2011","unstructured":"Pinderjit S, Rajnish K, Harinder S: Application of UV spectrophotometric method for analysis of gliclazide in pharmaceutical dosage forms. Int J Pharm Pharm Sci. 2011, 3: 259-260.","journal-title":"Int J Pharm Pharm Sci"},{"key":"771_CR23","doi-asserted-by":"crossref","unstructured":"Suzuki H, Miki M, Sekine Y, Kagemoto A, Negoro T, Maeda T, Hashimoto M: Determination of new hypoglycaemic drug Gliclazide in human serum by radio immunoassay. J Pharmacobiodyn. 4 (3): 217-225.","DOI":"10.1248\/bpb1978.4.217"},{"key":"771_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0378-4347(00)80108-5","volume":"223","author":"T Maeda","year":"1981","unstructured":"Maeda T, Yamaguchi T, Hashimoto M: Gas chromatographic determination of the hypoglycaemic agent gliclazide in plasma. J Chromatogr B Biomed Sci Appl. 1981, 223: 357-363. 10.1016\/S0378-4347(00)80108-5.","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"771_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.chroma.2004.12.097","volume":"1088","author":"CY Kuo","year":"2005","unstructured":"Kuo CY, Wu SM: High-performance liquid chromatography with electrochemical detection for analysis of gliclazide in plasma. J Chromatogr A. 2005, 1088: 131-135. 10.1016\/j.chroma.2004.12.097.","journal-title":"J Chromatogr A"},{"key":"771_CR26","first-page":"4258","volume":"21","author":"G Damanjeet","year":"2009","unstructured":"Damanjeet G, Lakshmi GG: HPLC method for determination of Gliclazide in human serum. Asian j Chem. 2009, 21: 4258-4264.","journal-title":"Asian j Chem"},{"key":"771_CR27","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jpba.2004.02.025","volume":"35","author":"JY Park","year":"2004","unstructured":"Park JY, Kim KA, Kim SL, Park PW: Quantification of gliclazide by semi-micro high-performance liquid chromatography: application to a bioequivalence study of two formulations in healthy subjects. J Pharm Biomed Anal. 2004, 35: 943-949. 10.1016\/j.jpba.2004.02.025.","journal-title":"J Pharm Biomed Anal"},{"key":"771_CR28","first-page":"231","volume":"4","author":"Y Jia-Feng","year":"2004","unstructured":"Jia-Feng Y: Determination of Gliclazide in human plasma by high performance liquid chromatography. Asian J Drug Metab Pharmacokinet. 2004, 4: 231-234.","journal-title":"Asian J Drug Metab Pharmacokinet"},{"key":"771_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1570-0232(01)00618-3","volume":"773","author":"HH Maurer","year":"2002","unstructured":"Maurer HH, Kratzsch C, Kraemer T, Peters FT, Weber AA: Screening, library-assisted identification and validated quantification of oral antidiabetics of the sulfonylurea-type in plasma by atmospheric pressure chemical ionization liquid chromatography-mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2002, 773: 63-73.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"12","key":"771_CR30","first-page":"653","volume":"58","author":"CY Wang","year":"2008","unstructured":"Wang CY, Zhang W, Xiang BR, Yu LY, Ma PC: Liquid chromatography - mass spectrometry method for the determination of gliclazide in human plasma and application to a pharmacokinetic study of gliclazide sustained release tablets. Arzneimittelforschung. 2008, 58 (12): 653-658.","journal-title":"Arzneimittelforschung"},{"key":"771_CR31","first-page":"277","volume":"4","author":"V Ediga","year":"2012","unstructured":"Ediga V, Krishna R, Chandra KS: A new simple RP-HPLC method for simultaneous estimation of Metformin Hcl and Gliclazide tablet dosage form. Int J Pharm Bio Sci. 2012, 4: 277-283.","journal-title":"Int J Pharm Bio Sci"},{"key":"771_CR32","first-page":"83","volume":"9","author":"F Kanij","year":"2010","unstructured":"Kanij F, Md Zakir R, Tasnuva H, Mohammad Abul Kalam A, Md Selim R: Development and validation of a simple method for simultaneous estimation of Metformin hydrochloride and gliclazide in tablets by using RP-HPLC. Dhaka Univ J. Pharm Sci. 2010, 9: 83-89.","journal-title":"Dhaka Univ J. Pharm Sci"},{"key":"771_CR33","first-page":"813","volume":"2","author":"PN Dhabale","year":"2010","unstructured":"Dhabale PN, Seervi CR: Simultaneous UV spectrophotometric method for estimation of gliclazide and metformine hydrochloride in tablet dosage form. Int J Chem Tech Res. 2010, 2: 813-817.","journal-title":"Int J Chem Tech Res"},{"key":"771_CR34","first-page":"1559","volume":"2","author":"PD Ketan","year":"2011","unstructured":"Ketan PD, Parthika AN, Yadvendra KA: Development and validation of spectrophotometric method for simultaneous estimation of gliclazide and metformin hydrochloride in bulk and tablet dosage form by simultaneous equation method. Int J Pharm Sci Res. 2011, 2: 1559-1563.","journal-title":"Int J Pharm Sci Res"},{"key":"771_CR35","first-page":"72","volume":"4","author":"M Nazar Mustafa","year":"2012","unstructured":"Nazar Mustafa M, Anurekha J: Simultaneous estimation of metformin hydrochloride, pioglitazone hydrochloride and gliclazide by validated rp-hplc method in solid dosage form. Int J Pharm Pharm Sci. 2012, 4: 72-76.","journal-title":"Int J Pharm Pharm Sci"},{"issue":"4","key":"771_CR36","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1155\/2009\/298379","volume":"6","author":"G Rathinavel","year":"2009","unstructured":"Rathinavel G, Umanath U, JValaramathy J, Samuel Joshua L, Selvin Thanuja C, Ganesh M, Shivkumar T, Priyadarsini R: RP-HPLC method for simultaneous estimation of rosiglitazone and gliclazide in tablets. E J chem. 2009, 6 (4): 1188-1192. 10.1155\/2009\/298379.","journal-title":"E J chem"},{"key":"771_CR37","first-page":"752","volume":"67","author":"AV Kasture","year":"2005","unstructured":"Kasture AV, Ramteke M: Simultaneous UV-Spectrophotometric methods for the estimation of Atenolol and Nifedipine in solid dosage forms. Ind J Pharm Sci. 2005, 67: 752-754.","journal-title":"Ind J Pharm Sci"},{"key":"771_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/BF03246509","volume":"6","author":"B Hemmateenejada","year":"2009","unstructured":"Hemmateenejada B, Miri R, Kamali R: A Kinetic spectrophotometric method for determination of amlodipine and Nifedipine in pharmaceutical preparations. J Iran Chem Soc. 2009, 6: 113-120. 10.1007\/BF03246509.","journal-title":"J Iran Chem Soc"},{"key":"771_CR39","doi-asserted-by":"crossref","first-page":"915","DOI":"10.18388\/abp.2005_3407","volume":"52","author":"N Rahman","year":"2005","unstructured":"Rahman N, Najmul S, Azmi H: New spectrophotometric methods for the determination of nifedipine in pharmaceutical formulations. Acta Biochim Pol. 2005, 52: 915-922.","journal-title":"Acta Biochim Pol"},{"key":"771_CR40","first-page":"187","volume":"69","author":"CSP Sastry","year":"1997","unstructured":"Sastry CSP, Chintalapati R, Venkateswarlu R: A simple spectrophotometric method for estimation of nifedipine. J Inst Chem. 1997, 69: 187-","journal-title":"J Inst Chem"},{"key":"771_CR41","first-page":"74","volume":"2","author":"R Revathi","year":"2010","unstructured":"Revathi R, Ethiraj T, Saravanan VS, Ganeshan V, Saranya V, Sengottuvel T: New spectrophotometric determination of nifedipine using hydrotropic solubilization. Int J Pharm Pharm Sci. 2010, 2: 74-76.","journal-title":"Int J Pharm Pharm Sci"},{"key":"771_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2228-5547-3-1","volume":"3","author":"AA Segun","year":"2012","unstructured":"Segun AA, Olajire AA, Olakunle SI: A new colorimetric method for thedetermination of nifedipine tablets by derivatization using 4-carboxyl 2,6dinitrobenzene diazonium ion. Int J Ind Chem. 2012, 3: 1-8. 10.1186\/2228-5547-3-1.","journal-title":"Int J Ind Chem"},{"key":"771_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0021-9673(99)01094-8","volume":"870","author":"M Yritia","year":"2000","unstructured":"Yritia M, Parra P, Igelisias E, Barbanoj JM: Quantitation of nifedipine inhuman plasma by on-line solid-phase extraction and high-performanceliquid chromatography. J Chromatog A. 2000, 870: 115-119. 10.1016\/S0021-9673(99)01094-8.","journal-title":"J Chromatog A"},{"issue":"839","key":"771_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jchromb.2006.03.048","volume":"24","author":"D Zendelovska","year":"2006","unstructured":"Zendelovska D, Simeska S, Sibinovska O, Kostova E, Milosevska K, Jakovski K, Jovanovska E, Kikerkov I, Trojacanec J, Zafirov D: Development of an HPLC method for the determination of nifedipine in human plasma by solid-phase extraction. J Chromatogr B Analyt Technol Biomed Life Sci. 2006, 24 (839): 85-88.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"771_CR45","first-page":"610","volume":"2","author":"Y Awad Uday","year":"2011","unstructured":"Awad Uday Y, Shravan Kumar P, Dinesh Kumar A, Bari S: Estimation of nifedipine by reverse phase high performance liquid chromatography tablet dosage form. Int. J. of Pharm. & Life Sci. 2011, 2: 610-612.","journal-title":"Int. J. of Pharm. & Life Sci"},{"issue":"5","key":"771_CR46","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4314\/tjpr.v8i5.48093","volume":"8","author":"M Ahmad","year":"2009","unstructured":"Ahmad M, Ahmad T, Sultan RA, Murtaza G: Pharmacokinetic Study ofNifedipine in Healthy Adult Male Human Volunteers. Trop J Pharm Res. 2009, 8 (5): 385-391.","journal-title":"Trop J Pharm Res"},{"key":"771_CR47","first-page":"45","volume":"52","author":"A Mahmood","year":"2010","unstructured":"Mahmood A, Tasneem A, Rafi AS, Jamal K, Ghulam M: Bioavailability andpharamcotherapeutics of nifedipine in human after single oral dose administration. Acta Pharmaceutica Sciencia. 2010, 52: 45-54.","journal-title":"Acta Pharmaceutica Sciencia"},{"key":"771_CR48","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0731-7085(00)00317-4","volume":"23","author":"VB Patravale","year":"2000","unstructured":"Patravale VB, Nair VB, Gore SP: High performance thin layer chromatographic determination of nifedipine from bulk drug and from pharmaceuticals. J Pharm Biomed Anal. 2000, 23: 623-627. 10.1016\/S0731-7085(00)00317-4.","journal-title":"J Pharm Biomed Anal"},{"key":"771_CR49","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0021-9673(95)00112-Z","volume":"700","author":"AE Bretnall","year":"1995","unstructured":"Bretnall AE, Clarke GS: Investigation and optimisation of the use of micellar electrokinetic chromatography for the analysis of six cardiovascular drugs. J Chromatogr A. 1995, 700: 173-178. 10.1016\/0021-9673(95)00112-Z.","journal-title":"J Chromatogr A"},{"key":"771_CR50","first-page":"317","volume":"52","author":"V Dumitrescu","year":"2001","unstructured":"Dumitrescu V, David V, Pavel A: Polarographic determination of nifedipine and chloramphinicol. Rev Chim. 2001, 52: 317-320.","journal-title":"Rev Chim"},{"key":"771_CR51","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00216-002-1703-2","volume":"375","author":"MM Ghoneim","year":"2003","unstructured":"Ghoneim MM, Tawfik A, Khashaba PY: Cathodic adsorptive stripping square-wave voltammertic detetermination of nifedipine drug in bulk, pharmaceutical formulation and human serum. Anal Bioanal Chem. 2003, 375: 369-375.","journal-title":"Anal Bioanal Chem"},{"key":"771_CR52","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/(SICI)1098-2728(1997)9:5<255::AID-LRA5>3.0.CO;2-#","volume":"9","author":"P Richter","year":"1997","unstructured":"Richter P, Toral MI, Quiroz G, Jaque P: Flow-through polarographic cell for flow-injection analysis determination of nifedipine in pharmaceutical formulations. Lab Rob Autom. 1997, 9: 255-262. 10.1002\/(SICI)1098-2728(1997)9:5<255::AID-LRA5>3.0.CO;2-#.","journal-title":"Lab Rob Autom"},{"key":"771_CR53","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0378-4347(98)00423-X","volume":"720","author":"B Streel","year":"1998","unstructured":"Streel B, Zimmer C, Sibernaler R, Ceccato A: Simultaneous determination of nifedipine and dehydronifedipine in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Biomed Sci Appl. 1998, 720: 119-128. 10.1016\/S0378-4347(98)00423-X.","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"771_CR54","first-page":"83","volume":"6","author":"R Srinivas","year":"2013","unstructured":"Srinivas R, Iqbal A, Nirmala N, Saral T, Arindam M: Estimation of nifedipine in human plasma by LC\/MS\/MS. Asian J Pharm Clin Res. 2013, 6: 83-86.","journal-title":"Asian J Pharm Clin Res"},{"key":"771_CR55","volume-title":"Guidance for Industry Food- Effect bio Availability and Fed Bio Equivalence Studies","author":"Food and Drug Administration (FDA)","year":"2002","unstructured":"Food and Drug Administration (FDA): Guidance for Industry Food- Effect bio Availability and Fed Bio Equivalence Studies. 2002, USA: U.S. Department of Health and Human services Food and Drug Administration Centre for Drug Evaluation and research (CDER)"},{"key":"771_CR56","volume-title":"Guidance for Industry Bio Availability and Fed Bio Equivalence Studies for Orally Administered Drug Products-General Considerations","author":"Food and Drug Administration (FDA)","year":"2003","unstructured":"Food and Drug Administration (FDA): Guidance for Industry Bio Availability and Fed Bio Equivalence Studies for Orally Administered Drug Products-General Considerations. 2003, USA: U.S. Department of Health and Human services Food and Drug Administration Centre for Drug Evaluation and research (CDER)"},{"key":"771_CR57","volume-title":"Validation of Analytical Procedure","author":"ICH Guideline, Q2(R1)","year":"2005","unstructured":"ICH Guideline, Q2(R1): Validation of Analytical Procedure. 2005, London: Text and Methodology London"}],"container-title":["Chemistry Central Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-153X-8-17.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-153X-8-17\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-153X-8-17.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T05:28:44Z","timestamp":1597555724000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/1752-153X-8-17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,11]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["771"],"URL":"https:\/\/doi.org\/10.1186\/1752-153x-8-17","relation":{},"ISSN":["1752-153X"],"issn-type":[{"value":"1752-153X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,11]]},"article-number":"17"}}